Effects of a selective glucocorticoid receptor agonist on osteoblastic and osteoclastic cells

被引：0
|
作者：
Rauner, M. [1 ]
Finger, S. [1 ]
Goettsch, C. [1 ]
Benad, R. [1 ]
Hofbauer, L. C. [1 ]
机构：
[1] Tech Univ Dresden, Div Endocrinol Diabet & Bone Dis, Dept Med 3, Fac Med, Dresden, Germany
来源：
BONE | 2009年 / 44卷 / 02期
关键词：
D O I：
10.1016/j.bone.2009.03.582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [41] Identification of the selective glucocorticoid receptor agonist Mapracorat as potential new drug for chronic wound therapy
    Wolff-Winiski, B.
    Schoefmann, N.
    Doerfler, P.
    Cabral, G.
    Stuetz, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S286 - S286
  • [42] Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective
    Ayroldi, Emira
    Macchiarulo, Antonio
    Riccardi, Carlo
    FASEB JOURNAL, 2014, 28 (12): : 5055 - 5070
  • [43] Selective Glucocorticoid Receptor Agonists: Glucocorticoid Therapy With No Regrets?
    Cooper, Mark S.
    Zhou, Hong
    Seibel, Markus J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (11) : 2238 - 2241
  • [44] Effects of ovariectomy on number of osteoblastic and osteoclastic progenitors in rat bone marrow.
    Mukohyama, H
    Kondo, H
    Kasugai, S
    Waki, Y
    Ozawa, S
    Kikukawa, I
    Ohya, K
    Ohyama, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S516 - S516
  • [45] Eldecalcitol effects on osteoblastic differentiation and function in the presence or absence of osteoclastic bone resorption
    Bu, Jie
    Du, Juan
    Shi, Lina
    Feng, Wei
    Wang, Wei
    Guo, Jie
    Hasegawa, Tomoka
    Liu, Hongrui
    Wang, Xuxia
    Li, Minqi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) : 2111 - 2121
  • [46] BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
    Zhang, Jin-Zhong
    Cavet, Megan E.
    VanDerMeid, Karl R.
    Salvador-Silva, Mercedes
    Lopez, Francisco J.
    Ward, Keith W.
    MOLECULAR VISION, 2009, 15 (278-81): : 2606 - 2616
  • [47] Agonist-free transformation of the glucocorticoid receptor in human B-lymphoma cells
    vandenBerg, JD
    Smets, LA
    vanRooij, H
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 57 (3-4): : 239 - 249
  • [48] Effects of selective prostaglandin E receptor agonists on transcriptional regulation of cyclooxygenase-2 in primary osteoblastic cells.
    Li, X
    Pilbeam, CC
    Chikazu, D
    Kawaguchi, H
    Alander, CB
    Woodiel, FN
    Raisz, LG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S491 - S491
  • [49] Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases
    Schaecke, H.
    Zollner, T. M.
    Doecke, W. D.
    Rehwinkel, H.
    Jaroch, S.
    Skuballa, W.
    Neuhaus, R.
    May, E.
    Zuegel, U.
    Asadullah, K.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (04) : 1088 - 1103
  • [50] Characterization of a Plant-Derived Selective Glucocorticoid Receptor Agonist (SEGRA) for the Treatment of Inflammatory Bowel Disease
    Reuter, Kerstin C.
    Ecker, Bettina M.
    Loitsch, Stefan Marcel
    Steinhilber, Dieter
    Stein, Jurgen
    GASTROENTEROLOGY, 2010, 138 (05) : S412 - S412
12345